Failure of postnatal ductus arteriosus closure in prostaglandin transporter-deficient mice

Circulation

Volumn 121, Issue 4, 2010, Pages 529-536

  Chang, Hee Yoon ^a   Locker, Joseph ^a   Lu, Run ^a   Schuster, Victor L ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Ductus arteriosus, patent; Genes; Heart failure; Prostaglandins

Indexed keywords

CARRIER PROTEIN; CYCLOOXYGENASE 1; INDOMETACIN; PROSTAGLANDIN E2; PROSTAGLANDIN TRANSPORTER; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; FIBROBLAST; GENE TARGETING; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNOCKOUT MOUSE; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PROSTAGLANDIN METABOLISM; PROSTAGLANDIN RELEASE; PROTEIN DEFICIENCY;

ANIMALS; CARDIOVASCULAR AGENTS; CELLS, CULTURED; DINOPROSTONE; DISEASE MODELS, ANIMAL; DUCTUS ARTERIOSUS; DUCTUS ARTERIOSUS, PATENT; FEMALE; FIBROBLASTS; INDOMETHACIN; LUNG; MICE; MICE, KNOCKOUT; ORGANIC ANION TRANSPORTERS; PREGNANCY; RECEPTORS, PROSTAGLANDIN E; SIGNAL TRANSDUCTION;

EID: 76349088956     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.862946     Document Type: Article

References (43)

1. Miller SB. Prostaglandins in health and disease: an overview. Semin Arthritis Rheum. 2006;36:37-49.
2. Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006; 114:1873-1882.
3. Ivey KN, Srivastava D. The paradoxical patent ductus arteriosus. J Clin Invest. 2006;116:2863-2865.
4. Segi E, Sugimoto Y, Yamasaki A, Aze Y, Oida H, Nishimura T, Murata T, Matsuoka T, Ushikubi F, Hirose M, Tanaka T, Yoshida N, Narumiya S, Ichikawa A. Patent ductus arteriosus and neonatal death in prostaglan-din receptor EP4-deficient mice. Biochem Biophys Res Commun. 1998; 246:7-12.
5. Loftin CD, Trivedi DB, Tiano HF, Clark JA, Lee CA, Epstein JA, Morham SG, Breyer MD, Nguyen M, Hawkins BM, Goulet JL, Smithies O, Koller BH, Langenbach R. Failure of ductus arteriosus closure and remodeling in neonatal mice deficient in cyclooxygenase-1 and cycloox-ygenase-2. Proc Natl Acad Sci USA. 2001;98:1059-1064.
6. Coggins KG, Latour A, Nguyen MS, Audoly L, Coffman TM, Koller BH. Metabolism of PGE2 by prostaglandin dehydrogenase is essential for remodeling the ductus arteriosus. Nat Med. 2002;8:91-92.
7. Nguyen M, Camenisch T, Snouwaert JN, Hicks E, Coffman TM, Anderson PA, Malouf NN, Koller BH. The prostaglandin receptor EP4 triggers remodelling of the cardiovascular system at birth. Nature. 1997; 390:78-81.
8. Reese J, Paria BC, Brown N, Zhao X, Morrow JD, Dey SK. Coordinated regulation of fetal and maternal prostaglandins directs successful birth and postnatal adaptation in the mouse. Proc Natl Acad Sci USA. 2000; 97:9759-9764.
9. Kanai N, Lu R, Satriano JA, Bao Y, Wolkoff AW, Schuster VL. Identification and characterization of a prostaglandin transporter. Science. 1995;268:866-869.
10. Nomura T, Chang HY, Lu R, Hankin J, Murphy RC, Schuster VL. Prostaglandin signaling in the renal collecting duct: release, reuptake, and oxidation in the same cell. J Biol Chem. 2005;280:28424-28429.
11. Nomura T, Lu R, Pucci ML, Schuster VL. The two-step model of prostaglandin signal termination: in vitro reconstitution with the prosta-glandin transporter and prostaglandin 15 dehydrogenase. Mol Pharmacol. 2004;65:973-978.
12. Eling TE, Anderson MW. Studies on the biosynthesis, metabolism and transport of prostaglandins by the lung. Agents Actions. 1976;6: 543-546.
13. Hawkins HJ, Wilson AG, Anderson MW, Eling TE. Uptake and metabolism of prostaglandins by isolated perfused lung: species comparisons and the role of plasma protein binding. Prostaglandins. 1977;14:251-259.
14. Sauer B. Inducible gene targeting in mice using the Cre/lox system. Methods. 1998;14:381-392.
15. Farley FW, Soriano P, Steffen LS, Dymecki SM. Widespread recom-binase expression using FLPeR (flipper) mice. Genesis. 2000;28: 106-110.
16. Lakso M, Pichel JG, Gorman JR, Sauer B, Okamoto Y, Lee E, Alt FW, Westphal H. Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci USA. 1996;93: 5860-5865.
17. Bao Y, Pucci ML, Chan BS, Lu R, Ito S, Schuster VL. Prostaglandin transporter PGT is expressed in cell types that synthesize and release prostanoids. Am J Physiol Renal Physiol. 2002;282:F1103-F1110.
18. Lu R, Kanai N, Bao Y, Schuster VL. Cloning, in vitro expression, and tissue distribution of a human prostaglandin transporter cDNA (hPGT). J Clin Invest. 1996;98:1142-1149.
19. Pucci ML, Bao Y, Chan B, Itoh S, Lu R, Copeland NG, Gilbert DJ, Schuster VL. Cloning of mouse prostaglandin transporter PGT cDNA: species-specific substrate affinities. Am J Physiol. 1999;277: R734-R741.
20. Kalina M, Socher R. Endocytosis in cultured rat alveolar type II cells: effect of lysosomotropic weak bases on the processes. J Histochem Cytochem. 1991;39:1337-1348.
21. Devereux TR, Fouts JR, Eling TE. Metabolism of prostaglandin PGF2 alpha by freshly isolated alveolar type II cells from lungs of adult male or pregnant rabbits. Prostagladins Leukot Med. 1987;27:43-52.
22. Tada T, Kishimoto H. Ultrastructural and histological studies on closure of the mouse ductus arteriosus. Acta Anat (Basel). 1990;139: 326-334.
23. Smith GC. The pharmacology of the ductus arteriosus. Pharmacol Rev. 1998;50:35-58.
24. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N Engl J Med. 1976;295:530-533.
25. Clyman RI, Mauray F, Roman C, Rudolph AM. PGE2 is a more potent vasodilator of the lamb ductus arteriosus than is either PGI2 or 6 keto PGF1alpha. Prostaglandins. 1978;16:259-264.
26. Clyman RI, Mauray F, Roman C, Rudolph AM, Heymann MA. Circulating prostaglandin E2 concentrations and patent ductus arteriosus in fetal and neonatal lambs. J Pediatr. 1980;97:455-461.
27. Clyman RI. Ductus arteriosus: current theories of prenatal and postnatal regulation. Semin Perinatol. 1987;11:64-71.
28. Yokoyama U, Minamisawa S, Quan H, Ghatak S, Akaike T, Segi-Nishida E, Iwasaki S, Iwamoto M, Misra S, Tamura K, Hori H, Yokota S, Toole BP, Sugimoto Y, Ishikawa Y. Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus. J Clin Invest. 2006;116:3026-3034.
29. Yokoyama U, Minamisawa S, Quan H, Akaike T, Suzuki S, Jin M, Jiao Q, Watanabe M, Otsu K, Iwasaki S, Nishimaki S, Sato M, Ishikawa Y. PGE2-activated Epac promotes neointimal cushion formation of the rat ductus arteriosus by a process distinct from that of PKA. J Biol Chem. 2008;283:28702-28709.
30. Thorburn GD. The placenta, PGE2 and parturition. Early Hum Dev. 1992;29:63-73.
31. Schuster VL. Prostaglandin transport. Prostaglandins Other Lipid Mediat. 2002;68-69:633-647.
32. Schuster VL. Molecular mechanisms of prostaglandin transport. Annu Rev Physiol. 1998;60:221-242.
33. Loftin CD, Trivedi DB, Langenbach R. Cyclooxygenase-1-selective inhibition prolongs gestation in mice without adverse effects on the ductus arteriosus. J Clin Invest. 2002;110:549-557.
34. Baragatti B, Brizzi F, Ackerley C, Barogi S, Ballou LR, Coceani F. Cyclooxygenase-1 and cyclooxygenase-2 in the mouse ductus arteriosus: individual activity and functional coupling with nitric oxide synthase. Br J Pharmacol. 2003;139:1505-1515.
35. Sodini D, Baragatti B, Barogi S, Laubach VE, Coceani F. Indomethacin promotes nitric oxide function in the ductus arteriosus in the mouse. Br J Pharmacol. 2008;153:1631-1640.
36. Reese J, Waleh N, Poole SD, Brown N, Roman C, Clyman RI. Chronic in utero cyclooxygenase inhibition alters PGE2-regulated ductus arte-riosus contractile pathways and prevents postnatal closure. Pediatr Res. 2009;66:155-161.
37. Challis JR, Dilley SR, Robinson JS, Thorburn GD. Prostaglandins in the circulation of the fetal lamb. Prostaglandins. 1976;11:1041-1052.
38. Mitchell MD, Brunt J, Clover L, Walker DW. Prostaglandins in the umbilical and uterine circulations during late pregnancy in the ewe. J Reprod Fertil. 1980;58:283-287.
39. Sun FF, Armour SB. Prostaglandin 15-hydroxy dehydrogenase and delta13 reductase levels in the lungs of maternal, fetal and neonatal rabbits. Prostaglandins. 1974;7:327-338.
40. Pucci ML, Endo S, Nomura T, Lu R, Khine C, Chan BS, Bao Y, Schuster VL. Coordinate control of prostaglandin E2 synthesis and uptake by hyperosmolarity in renal medullary interstitial cells. Am J Physiol Renal Physiol. 2006;290:F641-F649.
41. Topper JN, Cai J, Stavrakis G, Anderson KR, Woolf EA, Sampson BA, Schoen FJ, Falb D, Gimbrone MA Jr. Human prostaglandin transporter gene (hPGT) is regulated by fluid mechanical stimuli in cultured endo-thelial cells and expressed in vascular endothelium in vivo. Circulation. 1998;98:2396-2403.
42. Dekker RJ, Boon RA, Rondaij MG, Kragt A, Volger OL, Elderkamp YW, Meijers JC, Voorberg J, Pannekoek H, Horrevoets AJ. KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium. Blood. 2006;107:4354-4363.
43. McCormick SM, Eskin SG, McIntire LV, Teng CL, Lu CM, Russell CG, Chittur KK. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc Natl Acad Sci USA. 2001;98:8955-8960.